Annual CFI
-$273.91 M
-$273.91 M-100.00%
31 December 2023
Summary:
Apogee Therapeutics annual cash flow from investing activities is currently -$273.91 million, with the most recent change of -$273.91 million (-100.00%) on 31 December 2023.APGE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$146.38 M
+$2.33 M+1.57%
30 September 2024
Summary:
Apogee Therapeutics quarterly cash flow from investing activities is currently -$146.38 million, with the most recent change of +$2.33 million (+1.57%) on 30 September 2024. Over the past year, it has increased by +$87.84 million (+37.50%).APGE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$386.52 M
+$87.84 M+18.52%
30 September 2024
Summary:
Apogee Therapeutics TTM cash flow from investing activities is currently -$386.52 million, with the most recent change of +$87.84 million (+18.52%) on 30 September 2024. Over the past year, it has dropped by -$152.30 million (-65.03%).APGE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APGE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +37.5% | -65.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APGE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | +37.5% | +18.5% | |||
| 5 y | 5 years | at low | +37.5% | +18.5% | |||
| alltime | all time | <-9999.0% | at low | <-9999.0% | +37.5% | <-9999.0% | +18.5% |
Apogee Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$146.38 M(-1.6%) | -$386.52 M(-18.5%) |
| June 2024 | - | -$148.71 M(+187.4%) | -$474.36 M(+45.7%) |
| Mar 2024 | - | -$51.74 M(+30.4%) | -$325.65 M(+18.9%) |
| Dec 2023 | -$273.91 M | -$39.69 M(-83.1%) | -$273.91 M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$234.22 M(<-9900.0%) | -$234.22 M(<-9900.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00 | $0.00 |
| Dec 2022 | $0.00 | - | - |
FAQ
- What is Apogee Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Apogee Therapeutics?
- What is Apogee Therapeutics annual CFI year-on-year change?
- What is Apogee Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly CFI year-on-year change?
- What is Apogee Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Apogee Therapeutics?
- What is Apogee Therapeutics TTM CFI year-on-year change?
What is Apogee Therapeutics annual cash flow from investing activities?
The current annual CFI of APGE is -$273.91 M
What is the all time high annual CFI for Apogee Therapeutics?
Apogee Therapeutics all-time high annual cash flow from investing activities is $0.00
What is Apogee Therapeutics annual CFI year-on-year change?
Over the past year, APGE annual cash flow from investing activities has changed by -$273.91 M (-100.00%)
What is Apogee Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of APGE is -$146.38 M
What is the all time high quarterly CFI for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Apogee Therapeutics quarterly CFI year-on-year change?
Over the past year, APGE quarterly cash flow from investing activities has changed by +$87.84 M (+37.50%)
What is Apogee Therapeutics TTM cash flow from investing activities?
The current TTM CFI of APGE is -$386.52 M
What is the all time high TTM CFI for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is Apogee Therapeutics TTM CFI year-on-year change?
Over the past year, APGE TTM cash flow from investing activities has changed by -$152.30 M (-65.03%)